Disc Medicine (IRON) Other Non-Current Liabilities (2020 - 2023)
Disc Medicine (IRON) posted quarterly Other Non-Current Liabilities of $1.5 million for Q3 2023, little changed quarter-over-quarter from $1.5 million in Q2 2023.
Analysis
Disc Medicine (IRON) Other Non-Current Liabilities (2020 - 2023) Analysis & Trends
Disc Medicine (IRON) has reported Other Non-Current Liabilities for 3 consecutive years, with $1.5 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Other Non-Current Liabilities changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2023 stood at $1.5 million (changed N/A YoY), while the FY2021 annual figure was $6.4 million, up 2228.52% from the prior year.
- Other Non-Current Liabilities steadied at $1.5 million in Q3 2023 per IRON's latest filing, from $1.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $6.4 million in Q4 2021 and bottomed at $66000.0 in Q1 2020.
- Historically, Other Non-Current Liabilities has averaged $1.2 million across 3 years, with a median of $346000.0 in 2021.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 2228.52% in 2021 and fell as far as 378.79% in 2021.
- Disc Medicine's Other Non-Current Liabilities stood at $277000.0 in 2020, then soared by 2228.52% to $6.4 million in 2021, then sank by 76.74% to $1.5 million in 2023.
- Business Quant data shows IRON's Other Non-Current Liabilities at $1.5 million in Q3 2023, $1.5 million in Q2 2023, and $6.4 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Disc Medicine | 3.06 Bn | 3.06 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Dec 31, 2021 | 358,000.00 |
| Sep 30, 2021 | 366,000.00 |
| Jun 30, 2021 | 346,000.00 |
| Mar 31, 2021 | 316,000.00 |
| Dec 31, 2020 | 277,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Mar 31, 2020 | 66,000.00 |